BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 15, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for April 7, 2020

April 7, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agenus, Alnylam, Ascentage, Blaze, Immunomedics, Merck.
Read More

Other news to note for April 7, 2020

April 7, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alligator, Applied Biology, Beam, Biohaven, Biopharmx, Chromocell, Cullgen, Cytodyn, Cytovia, Fosun, Gilead, Imaginab, Infinity, Ingeneron, Iqvia, Intellistem, Karyopharm, La Jolla, Leading Biosciences, Lodo, Metrion, Nervgen, Pancella, Portola, Regeneron, Reneuron, Sanofi, Sirion.
Read More

In the clinic for April 7, 2020

April 7, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Bellus, Bicycle, Boston, Can-Fite, Crinetics, Inventiva, Kalvista, Kazia, Precision, Quantum, Seneca, Vaccinex.
Read More

Financings for April 7, 2020

April 7, 2020
Biopharmas raising money in public or private financings, including: Aytu, Lattice.
Read More

Appointments and advancements for April 7, 2020

April 7, 2020
New hires and promotions in the biopharma industry, including: Achilles, Exicure, Gadeta, Hemostemix, Oncoceutics, Polyneuron.
Read More

Regulatory actions for April 6, 2020

April 6, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medi-Tate, Merit Medical, Olympus.
Read More

Other news to note for April 6, 2020

April 6, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioivt, Bioreference Laboratories, Boston Heart Diagnostics, Carmat SA, Chandigarh University, Co-Diagnostics Inc., Deerfield Management, Itamar Medical Ltd., Luminex Corp., Mallinckrodt plc, Myriad Genetics, Inc., Nanomosaic, Nanostring, Openmed, Opko, Quotient, Safeguard Scientifics, Sano-Tek, Seaspine, Shockwave, Sleep Data Diagnostics, Synergy Laboratories, Theranica, Upscript.
Read More

Financings for April 6, 2020

April 6, 2020
Med-tech firms raising money in public or private financings, including: Genetic Technologies, Pulse Biosciences.
Read More

Appointments and advancements for April 6, 2020

April 6, 2020
New hires and promotions in the med-tech industry, including: Polarityte.
Read More

Regulatory actions for April 6, 2020

April 6, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, BMS, Daiichi, Eisai, GW, Histogen, Hope, Mallinckrodt, Mateon, Mesoblast, Novo Nordisk, Takeda, Tetra, Tracon.
Read More
Previous 1 2 … 1568 1569 1570 1571 1572 1573 1574 1575 1576 … 1715 1716 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 12, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing